GeneQuantum Healthcare (Suzhou)
GeneQuantum Healthcare (Suzhou) is a China-based biotechnology company running 2 late-stage cancer trials of GQ1005 and phase II in HER2-positive breast cancer.
Overview
GeneQuantum Healthcare (Suzhou), based in Suzhou, China, is a biotechnology company. GeneQuantum Healthcare develops bioconjugate therapeutics, including antibody-drug conjugates, using proprietary site-specific conjugation technologies. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing GQ1005 and phase II in HER2-positive breast cancer. The largest, NCT06464055 (A Study of GQ1010 in Subjects With Advanced Solid Tumours), plans to enrol 260 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 3 +3
- targets +2
- modalities +2